The fair featured a multidisciplinary group, including nursing, social work, EMS, pharmacy, medicine and surgical and radiology technologists.

John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research.

Using a technique developed at Vanderbilt University Medical Center, researchers identified antibodies that are excellent leads as potential therapies for human parainfluenza virus 3, a leading cause of acute and potentially fatal respiratory illness.

Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health (NIH) to create the world’s first, integrated knowledge base of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research.

While immune checkpoint inhibitors that target the PD-1 molecule on T-cells have proven to be effective with many cancers, these immunotherapies have not worked for acute myeloid leukemia (AML), but new research has identified a “cousin” molecule as a potential therapeutic target for AML. 

Psychologists at Monroe Carell Jr. Children’s Hospital at Vanderbilt will soon begin offering a workshop to help patients and families impacted by chronic pain and persistent functional symptoms.